Carl A. Laskin

9.2k total citations · 2 hit papers
96 papers, 4.8k citations indexed

About

Carl A. Laskin is a scholar working on Rheumatology, Immunology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Carl A. Laskin has authored 96 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Rheumatology, 35 papers in Immunology and 29 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Carl A. Laskin's work include Systemic Lupus Erythematosus Research (41 papers), Reproductive System and Pregnancy (18 papers) and Pregnancy and Medication Impact (18 papers). Carl A. Laskin is often cited by papers focused on Systemic Lupus Erythematosus Research (41 papers), Reproductive System and Pregnancy (18 papers) and Pregnancy and Medication Impact (18 papers). Carl A. Laskin collaborates with scholars based in Canada, United States and France. Carl A. Laskin's co-authors include Karen A. Spitzer, Joel G. Ray, Christine A. Clark, Jill P. Buyon, D. Ware Branch, Marta Guerra, Lisa R. Sammaritano, Joan T. Merrill, Michelle Petri and Michael D. Lockshin and has published in prestigious journals such as New England Journal of Medicine, Circulation and The Journal of Experimental Medicine.

In The Last Decade

Carl A. Laskin

92 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Comparison of Two Intensities of Warfarin for the Prevention of Recurrent Thrombosis in Patients with the Antiphospholipid Antibody Syndrome

2003 591 citations Mark Crowther, Jeff Ginsberg et al. New England Journal of Medicine profile →
Predictors of Pregnancy Outcomes in Patients With Lupus

2015 359 citations Jill P. Buyon, Mimi Kim et al. profile →

Peers

Countries citing papers authored by Carl A. Laskin

Since Specialization

Citations

This map shows the geographic impact of Carl A. Laskin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl A. Laskin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl A. Laskin more than expected).

Fields of papers citing papers by Carl A. Laskin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carl A. Laskin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl A. Laskin. The network helps show where Carl A. Laskin may publish in the future.

Co-authorship network of co-authors of Carl A. Laskin

This figure shows the co-authorship network connecting the top 25 collaborators of Carl A. Laskin. A scholar is included among the top collaborators of Carl A. Laskin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl A. Laskin. Carl A. Laskin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A clinical care pathway for managing pregnancy in patients with inflammatory arthritis 2025 ·Clinical Rheumatology ·Neda Amiri, (unknown), Carl A. Laskin, (unknown), (unknown)	0
2	An educational tool to improve PREeclamPsia knowledge and Aspirin adheRence in lupus prEgnancies: the PREPARE trial 2025 ·Lara D. Veeken ·(unknown), Arielle Mendel, Isabelle Malhamé, Megan R.W. Barber, Ann E. Clarke, Paul R. Fortin, John G. Hanly, Alexandra Legge, Christine Peschken, Carl A. Laskin, Zahi Touma, Murray B. Urowitz, Sasha Bernatsky, Évelyne Vinet	0
3	Pregnancy-associated exposure reduction to medications used for antiphospholipid syndrome: a systematic review 2025 ·(unknown), (unknown), Karen A. Spitzer, Carl A. Laskin, Shinya Ito	0
4	Genetics of Neonatal Lupus Erythematosus Risk and Specific Manifestations 2024 ·The Journal of Rheumatology ·(unknown), (unknown), Jingjing Cao, (unknown), (unknown), (unknown), Edgar Jaeggi, Andrea Knight, Carl A. Laskin, (unknown), Earl D. Silverman, Linda T. Hiraki	1
5	Ethnicity and Neonatal Lupus Erythematosus Manifestations Risk in a Large Multiethnic Cohort 2021 ·The Journal of Rheumatology ·(unknown), (unknown), Edgar Jaeggi, Andrea Knight, Carl A. Laskin, (unknown), (unknown), Earl D. Silverman, Linda T. Hiraki	8
6	Effect of in utero hydroxychloroquine exposure on the development of cutaneous neonatal lupus erythematosus 2018 ·Annals of the Rheumatic Diseases ·Julie Barsalou, N. Costedoat‐Chalumeau, (unknown), (unknown), (unknown), Patrick Brown, Carl A. Laskin, Nathalie Morel, K. Lévesque, Jill P. Buyon, Earl D. Silverman, Peter Izmirly	30
7	A meta-analysis of low-molecular-weight heparin to prevent pregnancy loss in women with inherited thrombophilia 2016 ·Blood ·Leslie Skeith, Marc Carrier, Risto Kaaja, Ida Martinelli, David Petroff, E Schleußner, Carl A. Laskin, Marc Rodger	57
8	Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study 2015 ·American Journal of Obstetrics and Gynecology ·Mimi Kim, Jill P. Buyon, Marta Guerra, Sarosh Rana, Dongsheng Zhang, Carl A. Laskin, Michelle Petri, Michael D. Lockshin, Lisa R. Sammaritano, D. Ware Branch, T. Flint Porter, Joan T. Merrill, Mary D. Stephenson, Qi Gao, S. Ananth Karumanchi, Jane E. Salmon	122
9	Effect of chronic hypertension on assisted pregnancy outcomes: a population-based study in Ontario, Canada 2015 ·Fertility and Sterility ·Natalie Dayan, Andrea Lanes, Mark Walker, Karen A. Spitzer, Carl A. Laskin	21
10	Idiopathic recurrent pregnancy loss is mostly caused by aneuploid embryos 2012 ·Fertility and Sterility ·J. Grifo, H. Danzer, T.H. Taylor, Carl A. Laskin, Ruth B. Lathi, S. Munné	5
11	Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies 2012 ·Arthritis & Rheumatism ·Michael D. Lockshin, Mimi Kim, Carl A. Laskin, Marta Guerra, D. Ware Branch, Joan T. Merrill, Michelle Petri, T. Flint Porter, Lisa R. Sammaritano, Mary D. Stephenson, Jill P. Buyon, Jane E. Salmon	261
12	Prolongation of the Atrioventricular Conduction in Fetuses Exposed to Maternal Anti-Ro/SSA and Anti-La/SSB Antibodies Did Not Predict Progressive Heart Block 2011 ·Journal of the American College of Cardiology ·Edgar Jaeggi, Earl D. Silverman, Carl A. Laskin, John‏ Kingdom, Fraser Golding, Roland Weber	60
13	The Importance of the Level of Maternal Anti-Ro/SSA Antibodies as a Prognostic Marker of the Development of Cardiac Neonatal Lupus Erythematosus 2010 ·Journal of the American College of Cardiology ·Edgar Jaeggi, Carl A. Laskin, Robert M. Hamilton, John‏ Kingdom, Earl D. Silverman	168
14	Low Molecular Weight Heparin and Aspirin for Recurrent Pregnancy Loss: Results from the Randomized, Controlled HepASA Trial 2009 ·The Journal of Rheumatology ·Carl A. Laskin, Karen A. Spitzer, Christine A. Clark, (unknown), Jeff Ginsberg, Gillian Hawker, John‏ Kingdom, (unknown), Michael Gent	230
15	Potential adverse effect of sperm DNA damage on embryo quality after ICSI 2005 ·Human Reproduction ·Armand Zini, James Meriano, (unknown), Keith Jarvi, Carl A. Laskin, Kenneth Cadesky	138
16	Binucleated and micronucleated blastomeres in embryos derived from human assisted reproduction cycles 2004 ·Reproductive BioMedicine Online ·James Meriano, Christine A. Clark, (unknown), Carl A. Laskin	76
17	A Comparison of Two Intensities of Warfarin for the Prevention of Recurrent Thrombosis in Patients with the Antiphospholipid Antibody Syndrome breakdown → 2003 ·New England Journal of Medicine ·Mark Crowther, Jeff Ginsberg, Jim A. Julian, Judah A. Denburg, Jack Hirsh, James D. Douketis, Carl A. Laskin, Paul R. Fortin, David R. Anderson, Clive Kearon, Ann E. Clarke, William Geerts, Melissa Forgie, David Green, Lorrie Costantini, (unknown), Sarah Wilson, Michael Gent, Michael J. Kovacs	591
18	Pharmacokinetic Profile of a Low-Molecular Weight Heparin (Reviparin) in Pregnant Patients 2000 ·Thrombosis Research ·Mark Crowther, Karen A. Spitzer, JoAnne Julian, Jeff Ginsberg, Marilyn Johnston, R. Crowther, Carl A. Laskin	53
19	Absent end-diastolic flow velocity waveforms in the umbilical artery—The subsequent pregnancy 1993 ·American Journal of Obstetrics and Gynecology ·Dan Farine, (unknown), Edmond N. Kelly, Robert J. Morrow, Carl A. Laskin, J. W. K. Ritchie	3
20	Studies of defective tolerance induction in NZB mice. Evidence for a marrow pre-T cell defect. 1982 ·The Journal of Experimental Medicine ·Carl A. Laskin, P A Smathers, J P Reeves, A D Steinberg	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact